enzalutamideapalutamidepazopanibabirateroneolaparibsunitinibcapecitabineimatinibosimertinibabemaciclib+8 more
… 5% had ovarian, renal or lung cancer. The involved drugs were: enzalutamide(25), apalutamide(14), abiraterone (9), abemaciclib(6), capecita…